DOCU vs PROF · P/E 15, rev $2.98B vs rev $10.7M
DocuSign Inc (DOCU) versus Profound Medical Corp (PROF) — a side-by-side from cached financials, not a winner call.
DocuSign Inc (DOCU) is a software - application company listed on US.
Profound Medical Corp (PROF) is a medical devices company listed on NASDAQ.
Latest reported DOCU revenue for 2025-01-31 was $2.98B. Net income was $1.07B. Revenue was up 7.8% from 2024-01-31 to 2025-01-31. DOCU currently screens at market cap $15.74B and trailing P/E 14.8.
Latest reported PROF revenue for 2024-12-31 was $10.7M. Net income was -$27.8M. Revenue was up 48.4% from 2023-12-31 to 2024-12-31. PROF currently screens at market cap $238.7M.
DOCU currently screens at market cap $15.74B and trailing P/E 14.8. PROF currently screens at market cap $238.7M.
Not investment advice. Open the DOCU and PROF stock pages for the full models.
Not investment advice.